Pomer krátenia spoločnosti Novabay Pharmaceuticals Inc
Aká je hodnota metriky Pomer krátenia spoločnosti Novabay Pharmaceuticals Inc?
Hodnota metriky Pomer krátenia spoločnosti Novabay Pharmaceuticals Inc je 0.58
Aká je definícia metriky Pomer krátenia?
Pomer krátenia (Short ratio) je pomer akcií predaných na krátko a priemerným denným objemom.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Pomer krátenia spoločností v sektore Health Care sektor na NYSEMKT v porovnaní so spoločnosťou Novabay Pharmaceuticals Inc
Čomu sa venuje spoločnosť Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Firmy s metrikou pomer krátenia podobnou spoločnosti Novabay Pharmaceuticals Inc
- Hodnota metriky Pomer krátenia spoločnosti L.S. Starrett Co je 0.57
- Hodnota metriky Pomer krátenia spoločnosti J. Alexanders Inc je 0.57
- Hodnota metriky Pomer krátenia spoločnosti Commerce Bancshares, (Missouri) je 0.57
- Hodnota metriky Pomer krátenia spoločnosti Revelo Resources je 0.57
- Hodnota metriky Pomer krátenia spoločnosti Cemtrex je 0.57
- Hodnota metriky Pomer krátenia spoločnosti Tenaz Corp je 0.57
- Hodnota metriky Pomer krátenia spoločnosti Novabay Pharmaceuticals Inc je 0.58
- Hodnota metriky Pomer krátenia spoločnosti LSI Industries je 0.59
- Hodnota metriky Pomer krátenia spoločnosti Alio Gold je 0.59
- Hodnota metriky Pomer krátenia spoločnosti Gensource Potash je 0.59
- Hodnota metriky Pomer krátenia spoločnosti Quintana Services je 0.59
- Hodnota metriky Pomer krátenia spoločnosti Sylla Gold Corp je 0.59
- Hodnota metriky Pomer krátenia spoločnosti Marvel Discovery je 0.59